Concepedia

Nosipho Ngubane

NN

9

Publications

2.4K

Citations

9

H-Index

2019

Active since

Affiliations

University of the Witwatersrand(Current)

TB Alliance

University College London

MRC Clinical Trials Unit at UCL

Helen Joseph Hospital

Nosipho Ngubane is an author at University of the Witwatersrand specializing in drug resistance, pharmacotherapy, and tuberculosis.

Top concepts

Publications per year

2019–2024

9

Publications

9

Treatment of Highly Drug-Resistant Pulmonary Tuberculosis

Francesca Conradie, Andreas H. Diacon, Nosipho Ngubane et al. · New England Journal of Medicine · 2020 · 962 citations · Full text

Bedaquiline–Pretomanid–Linezolid Regimens for Drug-Resistant Tuberculosis

Francesca Conradie, Tatevik R. Bagdasaryan, Pauline Howell et al. · New England Journal of Medicine · 2022 · 507 citations · Full text

A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis

Andrew Nunn, Patrick Phillips, Sarah Meredith et al. · New England Journal of Medicine · 2019 · 389 citations · Full text

A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis et al. · New England Journal of Medicine · 2022 · 318 citations · Full text

Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial

Ruth Goodall, Sarah Meredith, Andrew Nunn et al. · The Lancet · 2022 · 134 citations · Full text

, , +7

Rows per page

1–5 of 9